IRTC
iRhythm Technologies, Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
iRhythm Technologies (IRTC) Stock: Buy, Sell, or Hold?
$91.95
+3.27 (+3.69%)
▲
5d:
-29.37%
30d:
-13.3%
90d:
-27.28%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect IRTC Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (84%)
Quality Score
54/100
Position
OVERSOLD
30-Day Fair Range
$99.11 – $125.01
Position: OVERSOLD
Forward P/E & Valuation
56.7x
CHEAP
vs 114.5x historical avg
Wall Street Target
$155.64
+75.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$82.85 / $138.36
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: IRTC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When IRTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$73.96
Based on 13.8% avg growth
INTRINSIC VALUE TODAY
$45.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IRTC is currently trading at $91.95, which is considered oversold relative to its 30-day fair value range of $99.11 to $125.01. From a valuation perspective, the stock is trading at a discount (Forward PE: 56.7) compared to its historical average (114.5). Remarkably, the market is currently pricing in an annual earnings decline of 20.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IRTC is in a downtrend. Immediate support is located at $82.85, while resistance sits at $138.36. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $155.64 (+75.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IRTC is in a downtrend. Immediate support is located at $82.85, while resistance sits at $138.36. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $155.64 (+75.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$99.11 -
$125.01
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
Trading Range & Key Levels
30-Day Trading Range
$99.11 -
$125.01
Current vs Trading Range
OVERSOLD
Support Level
$82.85
Resistance Level
$138.36
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding IRTC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 75.5% below Wall St target ($155.64)
- NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
- CAUTION: 5-day price weakness (-29.4%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
56.68
Wall Street Target
$155.64
(+75.5%)
Revenue Growth (YoY)
14.9%
Profit Margin
-4.5%
Valuation Discount vs History
-20.9% cheaper
PE vs Historical
56.7 vs 114.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-20.9%
(market-implied from PE analysis)
1-Year Target
$79.81
(-10%)
2-Year Target
$71.83
(-19%)
3-Year Target
$64.65
(-27%)
3-Yr Target (if PE normalizes)
(PE: 57→115)
$130.60
(+47%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 56.7, Growth: 23.6%)
$167.55
(+89%)
Base:
(SPY PE: 19.9, Growth: 23.6%)
$58.71
(-34%)
Bear:
(PE: 16.9, Growth: 23.6%)
$49.90
(-44%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 56.7 to 114.5
Stabilization Target:
$179.15
(+102.0%)
PE Expansion Potential:
+102.0%
Share IRTC Analysis
Share this live IRTC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IRTC)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Sep 23, 2026
Daily AI digest
AI Retail Discussion Summary:
Butterfly Network (BFLY) surged 22.0% on strong volume following a Buy rating from Needham and a licensing agreement. iRhythm Holdings (IRTC) remained relatively stable.
Key Retail Themes:
Positive analyst coverage
Licensing agreement
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:37 PM ET
Data refreshes hourly during market hours. Next update: 3:37 PM
Data refreshes hourly during market hours. Next update: 3:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 54 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 45 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 48 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 33 SELL |
Advanced IRTC Option Strategies
Professional options setups generated by AI based on today's IRTC price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IRTC Research Pages
